Ai-biopharma

Curated by Signal

Developer of drugs for the treatment of human diseases and medicinal chemistry services

Overview

AI-biopharma is a developer of drugs for the treatment of human diseases and medicinal chemistry services. It provides AI-based drug discovery solutions. It offers various services such as computer-aided drug design, chemoInformatics – Database –3D Modeling – data analysis, pre-clinical candidate drug discovery and selection, medicinal chemistry lead identification, and others. It has developed AiB-001 that is liver targeted inhibitors of HBV Polymerase.

Key facts

Founded: 2023
Headquarters: Fremont, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Aluna Health
Text-based mobile health assistant for behavior change
Health TechnologyBoston, United States
Advantage Point Behavioral
Provider of telemedicine solutions for healthcare professionals
Health TechnologyNew York City, United States
DL Analytics
Provider of cervical cancer screening application for women
Health TechnologyCorvallis, United States

About Ai-biopharma

What does Ai-biopharma do?

AI-biopharma is a developer of drugs for the treatment of human diseases and medicinal chemistry services.

Where is Ai-biopharma headquartered?

Ai-biopharma is headquartered in Fremont, United States.

When was Ai-biopharma founded?

Ai-biopharma was founded in 2023.

Which sector is Ai-biopharma in?

Ai-biopharma operates in Health Technology.

Who are Ai-biopharma's competitors?

Companies similar to Ai-biopharma include Aluna Health, Advantage Point Behavioral, and DL Analytics.